🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

This #LungCancerConsidered episode explores issues facing clinicians/researchers treating Chinese pts. w/#NSCLC+EGFR mutations. W/host Chunxia Su & guests Jie Wang (Chinese Academy of Medical Science) & Yi-Long Wu (Guangdong Lung Cancer Institute): bit.ly/EGFRinChina #LCSM

Going on now at #WCLC23, Michael Boyer, Chunxia Su(Susu), Stephen V Liu, MD & Noemi Reguart are presenting the topic "Advancing Immunotherapy in ES-SCLC". Join us! #LCSM

Today, the #IASLC released its Global Survey on Biomarker Testing. To discuss the importance of this survey & its underlying issues, Stephen V Liu, MD discusses some of the barriers to biomarker testing w/@DeboraBrunoMD1, Rami Manochakian MD, FASCO Cancer Education & Matthew Smeltzer. Listen: bit.ly/BMT24

Chunxia Su(Susu) Misako Nagasaka Molly Li Herbert Loong, MBBS, FASCO Narjust Florez, MD, FASCO IvyLorena_Md Teresa Gorría Clarissa Mathias Vladmir C. Cordeiro de Lima, MD, PhD @ArielleElkrief Nicolas Marcoux MD, FRCPC Alfredo Addeo MD Maurice Perol Solange Peters

So proud to be one of the host!

Happy to be recorded my grow up!

🌻☺️a meaningful activity to attend

Heterogeneity in advanced pulmonary sarcomatoid carcinoma and its effi... sciencedirect.com/science/articl… We have submitted more than ten times for this work, finally accepted!the reviewer's opinion: this is a landmarkstudy ! feel that there is no need for modesty in scientific research.

Part of an ongoing series of podcasts in world languages, this episode brings together 4 leading Chinese #lungcancer experts to discuss current research/clinical issues, in Mandarin. W/Dr. Chunxia Su, Dr. Xiuning Le, Dr. Jianming Ying & Professor Li Zhang: bit.ly/LCCMandarin

So proud to be part of the series podcast for 50 anniversary. We recorded this special episode on site San Diego WCLC 2024!

A special tribute to the 50th anniversary of the IASLC, this episode was recorded live in San Diego on WCLC2024！

Join us today! The Rest of the Pie: State of the Art for “Other” Targets 🥧 ⏰ Tuesday Sept 10 , 1:30 pm 📍 room 32AB Chul Kim Susan Combs Scott, MD Giannis Mountzios Chunxia Su(Susu) KORINA PATELI-BELL

Really great session on rare targets in NSCLC at #WCLC24 chaired by Drs. Chul Kim Ilit Turgeman with Drs. Chunxia Su(Susu) Susan Combs Scott, MD Giannis Mountzios - lots to keep track of. Refreshing progress.

A special honor to be one of the IASLC podcast’ (lung cancer considered) guest host for 3 years! With all the hosts from all of the world!

My team finished an IIT-Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemo in extensive-SCLC and explored a non-invasive model to guide the treatment ,which published on STTT.

I feel humbled to belong to this family of thoracic oncologists. I feel grateful for the friendship of this community. Marina Garassino: you deserve all the best this life can bring to you, happiness and love. ❤️ #lcsm #ASCO25

Special 2025 ASCO, great chance to learn from so many stars of lung cancer circle, meet old friends and make new friends!@StephenVLiu Xiuning Le MD PhD Marina Garassino IASLC

How should clinicians approach resectable EGFR-mutant #NSCLC? On the latest #LungCancerConsidered episode, Stephen V Liu, MD moderates a case discussion with Collin Blakely MD, PhD and Chunxia Su(Susu), covering evolving strategies and clinical decision-making. 🎧 bit.ly/VTBregfrnsclc